However, understanding the appropriate duration for their use requires a careful evaluation of clinical studies, patient experiences, and ongoing discussions with your healthcare provider
TP508 injected into the fracture gap promotes fracture healing and increased blood vessel formation [95, 97, 102]
Medically reviewed by Charles Kamen, MD, board-certified neurologist The short answer No, the FDA did not approve BPC-157
Thinning skin, vasculitis, purpuric dermatosis, platelet deficiency, liver disease, vitamin K deficiency, vitamin C deficiency, moving your body during the injection, or dehydration may also cause bruising
Antioxidant Properties Research in rats has shown that BPC-157 can neutralize certain oxidative stress markers like nitric oxide and malondialadehyde (MDA) [3]
But what do I know